Does TOBRAMYCIN Cause Infective pulmonary exacerbation of cystic fibrosis? 504 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 504 reports of Infective pulmonary exacerbation of cystic fibrosis have been filed in association with TOBRAMYCIN (TOBRAMYCIN). This represents 4.4% of all adverse event reports for TOBRAMYCIN.
504
Reports of Infective pulmonary exacerbation of cystic fibrosis with TOBRAMYCIN
4.4%
of all TOBRAMYCIN reports
16
Deaths
435
Hospitalizations
How Dangerous Is Infective pulmonary exacerbation of cystic fibrosis From TOBRAMYCIN?
Of the 504 reports, 16 (3.2%) resulted in death, 435 (86.3%) required hospitalization, and 12 (2.4%) were considered life-threatening.
Is Infective pulmonary exacerbation of cystic fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOBRAMYCIN. However, 504 reports have been filed with the FAERS database.
What Other Side Effects Does TOBRAMYCIN Cause?
Off label use (1,467)
Death (888)
Cough (738)
Dyspnoea (706)
Pneumonia (700)
Hospitalisation (688)
Condition aggravated (669)
Cystic fibrosis (646)
Drug ineffective (453)
Acute kidney injury (372)
What Other Drugs Cause Infective pulmonary exacerbation of cystic fibrosis?
IVACAFTOR\LUMACAFTOR (1,417)
IVACAFTOR\TEZACAFTOR (1,211)
ELEXACAFTOR\IVACAFTOR\TEZACAFTOR (781)
IVACAFTOR (550)
AZTREONAM LYSINE (385)
DORNASE ALFA (245)
AZTREONAM (99)
PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (50)
ALBUTEROL (43)
OMALIZUMAB (38)
Which TOBRAMYCIN Alternatives Have Lower Infective pulmonary exacerbation of cystic fibrosis Risk?
TOBRAMYCIN vs TOBRAMYCIN\TOBRAMYCIN
TOBRAMYCIN vs TOCILIZUMAB
TOBRAMYCIN vs TOCILIZUMAB-AAZG
TOBRAMYCIN vs TOCOPHEROL
TOBRAMYCIN vs TOFACITINIB